nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—CASP9—prostate cancer	0.353	0.569	CbGaD
Hydroxocobalamin—TCN2—prostate cancer	0.268	0.431	CbGaD
Hydroxocobalamin—CUBN—prostate gland—prostate cancer	0.00311	0.0424	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—CASP9—prostate cancer	0.00301	0.512	CrCbGaD
Hydroxocobalamin—MMAA—prostate gland—prostate cancer	0.00294	0.0401	CbGeAlD
Hydroxocobalamin—TCN1—prostate gland—prostate cancer	0.0028	0.0382	CbGeAlD
Hydroxocobalamin—MMAB—prostate gland—prostate cancer	0.00276	0.0376	CbGeAlD
Hydroxocobalamin—CASP9—prostate gland—prostate cancer	0.00258	0.0351	CbGeAlD
Hydroxocobalamin—AMN—renal system—prostate cancer	0.00252	0.0343	CbGeAlD
Hydroxocobalamin—TCN2—prostate gland—prostate cancer	0.00252	0.0343	CbGeAlD
Hydroxocobalamin—CUBN—epithelium—prostate cancer	0.00229	0.0311	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—TCN2—prostate cancer	0.00228	0.388	CrCbGaD
Hydroxocobalamin—TCN2—seminal vesicle—prostate cancer	0.00213	0.029	CbGeAlD
Hydroxocobalamin—CUBN—renal system—prostate cancer	0.00212	0.0289	CbGeAlD
Hydroxocobalamin—CUBN—urethra—prostate cancer	0.00208	0.0284	CbGeAlD
Hydroxocobalamin—MUT—prostate gland—prostate cancer	0.00198	0.0269	CbGeAlD
Hydroxocobalamin—TCN1—urethra—prostate cancer	0.00188	0.0255	CbGeAlD
Hydroxocobalamin—MTRR—prostate gland—prostate cancer	0.00178	0.0242	CbGeAlD
Hydroxocobalamin—CASP9—renal system—prostate cancer	0.00176	0.0239	CbGeAlD
Hydroxocobalamin—TCN2—renal system—prostate cancer	0.00171	0.0234	CbGeAlD
Hydroxocobalamin—TCN2—urethra—prostate cancer	0.00168	0.0229	CbGeAlD
Hydroxocobalamin—MUT—seminal vesicle—prostate cancer	0.00167	0.0228	CbGeAlD
Hydroxocobalamin—AMN—testis—prostate cancer	0.00163	0.0222	CbGeAlD
Hydroxocobalamin—MTR—prostate gland—prostate cancer	0.00155	0.0211	CbGeAlD
Hydroxocobalamin—MTRR—seminal vesicle—prostate cancer	0.0015	0.0205	CbGeAlD
Hydroxocobalamin—TCN1—bone marrow—prostate cancer	0.00144	0.0197	CbGeAlD
Hydroxocobalamin—CUBN—testis—prostate cancer	0.00137	0.0187	CbGeAlD
Hydroxocobalamin—MUT—renal system—prostate cancer	0.00135	0.0184	CbGeAlD
Hydroxocobalamin—MUT—urethra—prostate cancer	0.00132	0.018	CbGeAlD
Hydroxocobalamin—MTR—seminal vesicle—prostate cancer	0.00131	0.0179	CbGeAlD
Hydroxocobalamin—MMAA—testis—prostate cancer	0.0013	0.0177	CbGeAlD
Hydroxocobalamin—MMAB—testis—prostate cancer	0.00122	0.0166	CbGeAlD
Hydroxocobalamin—MTRR—renal system—prostate cancer	0.00121	0.0165	CbGeAlD
Hydroxocobalamin—MTRR—urethra—prostate cancer	0.00119	0.0162	CbGeAlD
Hydroxocobalamin—AMN—lymph node—prostate cancer	0.00118	0.0161	CbGeAlD
Hydroxocobalamin—CASP9—testis—prostate cancer	0.00114	0.0155	CbGeAlD
Hydroxocobalamin—TCN2—testis—prostate cancer	0.00111	0.0151	CbGeAlD
Hydroxocobalamin—MTR—renal system—prostate cancer	0.00106	0.0144	CbGeAlD
Hydroxocobalamin—MTR—urethra—prostate cancer	0.00104	0.0141	CbGeAlD
Hydroxocobalamin—MUT—bone marrow—prostate cancer	0.00102	0.0139	CbGeAlD
Hydroxocobalamin—CUBN—lymph node—prostate cancer	0.000993	0.0135	CbGeAlD
Hydroxocobalamin—MMAA—lymph node—prostate cancer	0.000939	0.0128	CbGeAlD
Hydroxocobalamin—MTRR—bone marrow—prostate cancer	0.000916	0.0125	CbGeAlD
Hydroxocobalamin—MMAB—lymph node—prostate cancer	0.000881	0.012	CbGeAlD
Hydroxocobalamin—MUT—testis—prostate cancer	0.000872	0.0119	CbGeAlD
Hydroxocobalamin—CASP9—lymph node—prostate cancer	0.000823	0.0112	CbGeAlD
Hydroxocobalamin—TCN2—lymph node—prostate cancer	0.000803	0.0109	CbGeAlD
Hydroxocobalamin—MTR—bone marrow—prostate cancer	0.000799	0.0109	CbGeAlD
Hydroxocobalamin—MTRR—testis—prostate cancer	0.000783	0.0107	CbGeAlD
Hydroxocobalamin—MTR—testis—prostate cancer	0.000683	0.0093	CbGeAlD
Hydroxocobalamin—MUT—lymph node—prostate cancer	0.000632	0.00861	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—prostate cancer	0.00059	0.101	CrCbGaD
Hydroxocobalamin—MTRR—lymph node—prostate cancer	0.000568	0.00773	CbGeAlD
Hydroxocobalamin—MTR—lymph node—prostate cancer	0.000495	0.00674	CbGeAlD
Hydroxocobalamin—Urethral disorder—Docetaxel—prostate cancer	9.33e-05	0.000696	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Epirubicin—prostate cancer	9.32e-05	0.000695	CcSEcCtD
Hydroxocobalamin—Pruritus—Conjugated Estrogens—prostate cancer	9.29e-05	0.000692	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Etoposide—prostate cancer	9.26e-05	0.00069	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Estradiol—prostate cancer	9.25e-05	0.000689	CcSEcCtD
Hydroxocobalamin—Hot flush—Doxorubicin—prostate cancer	9.18e-05	0.000684	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Capecitabine—prostate cancer	9.11e-05	0.000679	CcSEcCtD
Hydroxocobalamin—Menopausal symptoms—Doxorubicin—prostate cancer	9.1e-05	0.000679	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Capecitabine—prostate cancer	9.08e-05	0.000677	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Estradiol—prostate cancer	9.07e-05	0.000676	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Goserelin—prostate cancer	9.07e-05	0.000676	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Capecitabine—prostate cancer	9.04e-05	0.000674	CcSEcCtD
Hydroxocobalamin—Malaise—Etoposide—prostate cancer	9e-05	0.00067	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Doxorubicin—prostate cancer	8.99e-05	0.00067	CcSEcCtD
Hydroxocobalamin—Pain—Estradiol—prostate cancer	8.98e-05	0.000669	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Conjugated Estrogens—prostate cancer	8.98e-05	0.000669	CcSEcCtD
Hydroxocobalamin—Eye disorder—Docetaxel—prostate cancer	8.9e-05	0.000663	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Docetaxel—prostate cancer	8.84e-05	0.000659	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Epirubicin—prostate cancer	8.83e-05	0.000658	CcSEcCtD
Hydroxocobalamin—Dizziness—Goserelin—prostate cancer	8.76e-05	0.000653	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Mitoxantrone—prostate cancer	8.73e-05	0.00065	CcSEcCtD
Hydroxocobalamin—Dizziness—Conjugated Estrogens—prostate cancer	8.68e-05	0.000647	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Estradiol—prostate cancer	8.66e-05	0.000645	CcSEcCtD
Hydroxocobalamin—Angiopathy—Docetaxel—prostate cancer	8.64e-05	0.000644	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Doxorubicin—prostate cancer	8.63e-05	0.000643	CcSEcCtD
Hydroxocobalamin—Eye disorder—Capecitabine—prostate cancer	8.62e-05	0.000642	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Mitoxantrone—prostate cancer	8.62e-05	0.000642	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Docetaxel—prostate cancer	8.6e-05	0.000641	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Docetaxel—prostate cancer	8.58e-05	0.00064	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Capecitabine—prostate cancer	8.56e-05	0.000638	CcSEcCtD
Hydroxocobalamin—Chills—Docetaxel—prostate cancer	8.54e-05	0.000637	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Docetaxel—prostate cancer	8.51e-05	0.000634	CcSEcCtD
Hydroxocobalamin—Chest pain—Etoposide—prostate cancer	8.49e-05	0.000633	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Epirubicin—prostate cancer	8.45e-05	0.00063	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	8.43e-05	0.000629	CcSEcCtD
Hydroxocobalamin—Discomfort—Etoposide—prostate cancer	8.39e-05	0.000625	CcSEcCtD
Hydroxocobalamin—Pain—Mitoxantrone—prostate cancer	8.37e-05	0.000624	CcSEcCtD
Hydroxocobalamin—Angiopathy—Capecitabine—prostate cancer	8.37e-05	0.000623	CcSEcCtD
Hydroxocobalamin—Rash—Goserelin—prostate cancer	8.35e-05	0.000623	CcSEcCtD
Hydroxocobalamin—Dermatitis—Goserelin—prostate cancer	8.35e-05	0.000622	CcSEcCtD
Hydroxocobalamin—Urticaria—Estradiol—prostate cancer	8.34e-05	0.000622	CcSEcCtD
Hydroxocobalamin—Mental disorder—Docetaxel—prostate cancer	8.34e-05	0.000622	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Capecitabine—prostate cancer	8.33e-05	0.000621	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Capecitabine—prostate cancer	8.31e-05	0.000619	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Estradiol—prostate cancer	8.3e-05	0.000619	CcSEcCtD
Hydroxocobalamin—Headache—Goserelin—prostate cancer	8.3e-05	0.000619	CcSEcCtD
Hydroxocobalamin—Erythema—Docetaxel—prostate cancer	8.29e-05	0.000618	CcSEcCtD
Hydroxocobalamin—Rash—Conjugated Estrogens—prostate cancer	8.28e-05	0.000617	CcSEcCtD
Hydroxocobalamin—Chills—Capecitabine—prostate cancer	8.27e-05	0.000617	CcSEcCtD
Hydroxocobalamin—Dermatitis—Conjugated Estrogens—prostate cancer	8.27e-05	0.000616	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Capecitabine—prostate cancer	8.24e-05	0.000614	CcSEcCtD
Hydroxocobalamin—Headache—Conjugated Estrogens—prostate cancer	8.22e-05	0.000613	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Doxorubicin—prostate cancer	8.17e-05	0.000609	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Etoposide—prostate cancer	8.14e-05	0.000607	CcSEcCtD
Hydroxocobalamin—Infection—Etoposide—prostate cancer	8.09e-05	0.000603	CcSEcCtD
Hydroxocobalamin—Mental disorder—Capecitabine—prostate cancer	8.08e-05	0.000602	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Mitoxantrone—prostate cancer	8.07e-05	0.000601	CcSEcCtD
Hydroxocobalamin—Erythema—Capecitabine—prostate cancer	8.03e-05	0.000598	CcSEcCtD
Hydroxocobalamin—Dysphagia—Epirubicin—prostate cancer	8.02e-05	0.000598	CcSEcCtD
Hydroxocobalamin—Tachycardia—Etoposide—prostate cancer	7.95e-05	0.000592	CcSEcCtD
Hydroxocobalamin—Skin disorder—Etoposide—prostate cancer	7.91e-05	0.000589	CcSEcCtD
Hydroxocobalamin—Nausea—Goserelin—prostate cancer	7.87e-05	0.000587	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Doxorubicin—prostate cancer	7.82e-05	0.000583	CcSEcCtD
Hydroxocobalamin—Nausea—Conjugated Estrogens—prostate cancer	7.8e-05	0.000581	CcSEcCtD
Hydroxocobalamin—Urticaria—Mitoxantrone—prostate cancer	7.78e-05	0.00058	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Estradiol—prostate cancer	7.74e-05	0.000577	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Mitoxantrone—prostate cancer	7.74e-05	0.000577	CcSEcCtD
Hydroxocobalamin—Eye disorder—Prednisone—prostate cancer	7.67e-05	0.000572	CcSEcCtD
Hydroxocobalamin—Angiopathy—Prednisone—prostate cancer	7.45e-05	0.000555	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Capecitabine—prostate cancer	7.45e-05	0.000555	CcSEcCtD
Hydroxocobalamin—Pruritus—Estradiol—prostate cancer	7.43e-05	0.000554	CcSEcCtD
Hydroxocobalamin—Dysphagia—Doxorubicin—prostate cancer	7.42e-05	0.000553	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Prednisone—prostate cancer	7.42e-05	0.000553	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Prednisone—prostate cancer	7.34e-05	0.000547	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Etoposide—prostate cancer	7.26e-05	0.000541	CcSEcCtD
Hydroxocobalamin—Malaise—Capecitabine—prostate cancer	7.24e-05	0.000539	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Mitoxantrone—prostate cancer	7.21e-05	0.000537	CcSEcCtD
Hydroxocobalamin—Mental disorder—Prednisone—prostate cancer	7.2e-05	0.000536	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Estradiol—prostate cancer	7.19e-05	0.000536	CcSEcCtD
Hydroxocobalamin—Erythema—Prednisone—prostate cancer	7.15e-05	0.000533	CcSEcCtD
Hydroxocobalamin—Chest pain—Docetaxel—prostate cancer	7.06e-05	0.000526	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Etoposide—prostate cancer	7.03e-05	0.000524	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	7.01e-05	0.000522	CcSEcCtD
Hydroxocobalamin—Pain—Etoposide—prostate cancer	6.96e-05	0.000519	CcSEcCtD
Hydroxocobalamin—Dizziness—Estradiol—prostate cancer	6.95e-05	0.000518	CcSEcCtD
Hydroxocobalamin—Chest pain—Capecitabine—prostate cancer	6.83e-05	0.000509	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	6.79e-05	0.000506	CcSEcCtD
Hydroxocobalamin—Oedema—Docetaxel—prostate cancer	6.77e-05	0.000504	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Docetaxel—prostate cancer	6.77e-05	0.000504	CcSEcCtD
Hydroxocobalamin—Discomfort—Capecitabine—prostate cancer	6.75e-05	0.000503	CcSEcCtD
Hydroxocobalamin—Infection—Docetaxel—prostate cancer	6.72e-05	0.000501	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Etoposide—prostate cancer	6.71e-05	0.0005	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Mitoxantrone—prostate cancer	6.7e-05	0.000499	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Docetaxel—prostate cancer	6.63e-05	0.000495	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Prednisone—prostate cancer	6.63e-05	0.000494	CcSEcCtD
Hydroxocobalamin—Rash—Estradiol—prostate cancer	6.62e-05	0.000494	CcSEcCtD
Hydroxocobalamin—Dermatitis—Estradiol—prostate cancer	6.62e-05	0.000493	CcSEcCtD
Hydroxocobalamin—Tachycardia—Docetaxel—prostate cancer	6.6e-05	0.000492	CcSEcCtD
Hydroxocobalamin—Headache—Estradiol—prostate cancer	6.58e-05	0.00049	CcSEcCtD
Hydroxocobalamin—Skin disorder—Docetaxel—prostate cancer	6.57e-05	0.00049	CcSEcCtD
Hydroxocobalamin—Agitation—Prednisone—prostate cancer	6.57e-05	0.00049	CcSEcCtD
Hydroxocobalamin—Oedema—Capecitabine—prostate cancer	6.55e-05	0.000488	CcSEcCtD
Hydroxocobalamin—Angioedema—Prednisone—prostate cancer	6.53e-05	0.000487	CcSEcCtD
Hydroxocobalamin—Infection—Capecitabine—prostate cancer	6.51e-05	0.000485	CcSEcCtD
Hydroxocobalamin—Urticaria—Etoposide—prostate cancer	6.47e-05	0.000482	CcSEcCtD
Hydroxocobalamin—Malaise—Prednisone—prostate cancer	6.45e-05	0.000481	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Etoposide—prostate cancer	6.44e-05	0.00048	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Capecitabine—prostate cancer	6.42e-05	0.000479	CcSEcCtD
Hydroxocobalamin—Tachycardia—Capecitabine—prostate cancer	6.39e-05	0.000477	CcSEcCtD
Hydroxocobalamin—Skin disorder—Capecitabine—prostate cancer	6.36e-05	0.000474	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Epirubicin—prostate cancer	6.34e-05	0.000473	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Epirubicin—prostate cancer	6.33e-05	0.000472	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Epirubicin—prostate cancer	6.3e-05	0.000469	CcSEcCtD
Hydroxocobalamin—Nausea—Estradiol—prostate cancer	6.24e-05	0.000465	CcSEcCtD
Hydroxocobalamin—Rash—Mitoxantrone—prostate cancer	6.17e-05	0.00046	CcSEcCtD
Hydroxocobalamin—Dermatitis—Mitoxantrone—prostate cancer	6.17e-05	0.00046	CcSEcCtD
Hydroxocobalamin—Headache—Mitoxantrone—prostate cancer	6.13e-05	0.000457	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	6.04e-05	0.000451	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Docetaxel—prostate cancer	6.03e-05	0.00045	CcSEcCtD
Hydroxocobalamin—Discomfort—Prednisone—prostate cancer	6.01e-05	0.000448	CcSEcCtD
Hydroxocobalamin—Eye disorder—Epirubicin—prostate cancer	6e-05	0.000447	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Etoposide—prostate cancer	6e-05	0.000447	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Epirubicin—prostate cancer	5.96e-05	0.000444	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Docetaxel—prostate cancer	5.96e-05	0.000444	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Doxorubicin—prostate cancer	5.87e-05	0.000437	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Doxorubicin—prostate cancer	5.85e-05	0.000436	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Docetaxel—prostate cancer	5.84e-05	0.000435	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Capecitabine—prostate cancer	5.84e-05	0.000435	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Prednisone—prostate cancer	5.83e-05	0.000435	CcSEcCtD
Hydroxocobalamin—Oedema—Prednisone—prostate cancer	5.83e-05	0.000435	CcSEcCtD
Hydroxocobalamin—Angiopathy—Epirubicin—prostate cancer	5.83e-05	0.000434	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Doxorubicin—prostate cancer	5.83e-05	0.000434	CcSEcCtD
Hydroxocobalamin—Nausea—Mitoxantrone—prostate cancer	5.81e-05	0.000433	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Epirubicin—prostate cancer	5.8e-05	0.000432	CcSEcCtD
Hydroxocobalamin—Infection—Prednisone—prostate cancer	5.8e-05	0.000432	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Epirubicin—prostate cancer	5.79e-05	0.000431	CcSEcCtD
Hydroxocobalamin—Pain—Docetaxel—prostate cancer	5.79e-05	0.000431	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Capecitabine—prostate cancer	5.77e-05	0.00043	CcSEcCtD
Hydroxocobalamin—Chills—Epirubicin—prostate cancer	5.76e-05	0.00043	CcSEcCtD
Hydroxocobalamin—Pruritus—Etoposide—prostate cancer	5.76e-05	0.000429	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Epirubicin—prostate cancer	5.74e-05	0.000428	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Prednisone—prostate cancer	5.72e-05	0.000426	CcSEcCtD
Hydroxocobalamin—Tachycardia—Prednisone—prostate cancer	5.69e-05	0.000424	CcSEcCtD
Hydroxocobalamin—Skin disorder—Prednisone—prostate cancer	5.67e-05	0.000422	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Capecitabine—prostate cancer	5.66e-05	0.000422	CcSEcCtD
Hydroxocobalamin—Mental disorder—Epirubicin—prostate cancer	5.63e-05	0.000419	CcSEcCtD
Hydroxocobalamin—Pain—Capecitabine—prostate cancer	5.6e-05	0.000418	CcSEcCtD
Hydroxocobalamin—Erythema—Epirubicin—prostate cancer	5.59e-05	0.000417	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Docetaxel—prostate cancer	5.58e-05	0.000416	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Etoposide—prostate cancer	5.57e-05	0.000415	CcSEcCtD
Hydroxocobalamin—Eye disorder—Doxorubicin—prostate cancer	5.55e-05	0.000414	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Doxorubicin—prostate cancer	5.52e-05	0.000411	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Capecitabine—prostate cancer	5.4e-05	0.000402	CcSEcCtD
Hydroxocobalamin—Angiopathy—Doxorubicin—prostate cancer	5.39e-05	0.000402	CcSEcCtD
Hydroxocobalamin—Dizziness—Etoposide—prostate cancer	5.38e-05	0.000401	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Doxorubicin—prostate cancer	5.37e-05	0.0004	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Doxorubicin—prostate cancer	5.36e-05	0.000399	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Docetaxel—prostate cancer	5.35e-05	0.000399	CcSEcCtD
Hydroxocobalamin—Chills—Doxorubicin—prostate cancer	5.33e-05	0.000397	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Doxorubicin—prostate cancer	5.31e-05	0.000396	CcSEcCtD
Hydroxocobalamin—Mental disorder—Doxorubicin—prostate cancer	5.21e-05	0.000388	CcSEcCtD
Hydroxocobalamin—Urticaria—Capecitabine—prostate cancer	5.2e-05	0.000388	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Epirubicin—prostate cancer	5.19e-05	0.000387	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Capecitabine—prostate cancer	5.18e-05	0.000386	CcSEcCtD
Hydroxocobalamin—Erythema—Doxorubicin—prostate cancer	5.17e-05	0.000386	CcSEcCtD
Hydroxocobalamin—Agitation—Epirubicin—prostate cancer	5.14e-05	0.000383	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Prednisone—prostate cancer	5.14e-05	0.000383	CcSEcCtD
Hydroxocobalamin—Rash—Etoposide—prostate cancer	5.13e-05	0.000383	CcSEcCtD
Hydroxocobalamin—Dermatitis—Etoposide—prostate cancer	5.13e-05	0.000382	CcSEcCtD
Hydroxocobalamin—Headache—Etoposide—prostate cancer	5.1e-05	0.00038	CcSEcCtD
Hydroxocobalamin—Malaise—Epirubicin—prostate cancer	5.04e-05	0.000376	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Docetaxel—prostate cancer	4.98e-05	0.000372	CcSEcCtD
Hydroxocobalamin—Nausea—Etoposide—prostate cancer	4.84e-05	0.00036	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Capecitabine—prostate cancer	4.83e-05	0.00036	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Prednisone—prostate cancer	4.81e-05	0.000358	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Doxorubicin—prostate cancer	4.8e-05	0.000358	CcSEcCtD
Hydroxocobalamin—Pruritus—Docetaxel—prostate cancer	4.79e-05	0.000357	CcSEcCtD
Hydroxocobalamin—Chest pain—Epirubicin—prostate cancer	4.76e-05	0.000355	CcSEcCtD
Hydroxocobalamin—Agitation—Doxorubicin—prostate cancer	4.75e-05	0.000354	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.73e-05	0.000352	CcSEcCtD
Hydroxocobalamin—Discomfort—Epirubicin—prostate cancer	4.7e-05	0.000351	CcSEcCtD
Hydroxocobalamin—Malaise—Doxorubicin—prostate cancer	4.67e-05	0.000348	CcSEcCtD
Hydroxocobalamin—Urticaria—Prednisone—prostate cancer	4.64e-05	0.000345	CcSEcCtD
Hydroxocobalamin—Pruritus—Capecitabine—prostate cancer	4.63e-05	0.000345	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Docetaxel—prostate cancer	4.63e-05	0.000345	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Prednisone—prostate cancer	4.61e-05	0.000344	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Epirubicin—prostate cancer	4.56e-05	0.00034	CcSEcCtD
Hydroxocobalamin—Oedema—Epirubicin—prostate cancer	4.56e-05	0.00034	CcSEcCtD
Hydroxocobalamin—Infection—Epirubicin—prostate cancer	4.53e-05	0.000338	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Capecitabine—prostate cancer	4.48e-05	0.000334	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Epirubicin—prostate cancer	4.48e-05	0.000334	CcSEcCtD
Hydroxocobalamin—Dizziness—Docetaxel—prostate cancer	4.47e-05	0.000333	CcSEcCtD
Hydroxocobalamin—Tachycardia—Epirubicin—prostate cancer	4.45e-05	0.000332	CcSEcCtD
Hydroxocobalamin—Skin disorder—Epirubicin—prostate cancer	4.43e-05	0.00033	CcSEcCtD
Hydroxocobalamin—Chest pain—Doxorubicin—prostate cancer	4.4e-05	0.000328	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.37e-05	0.000326	CcSEcCtD
Hydroxocobalamin—Discomfort—Doxorubicin—prostate cancer	4.35e-05	0.000324	CcSEcCtD
Hydroxocobalamin—Dizziness—Capecitabine—prostate cancer	4.33e-05	0.000323	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Prednisone—prostate cancer	4.3e-05	0.00032	CcSEcCtD
Hydroxocobalamin—Rash—Docetaxel—prostate cancer	4.27e-05	0.000318	CcSEcCtD
Hydroxocobalamin—Dermatitis—Docetaxel—prostate cancer	4.26e-05	0.000318	CcSEcCtD
Hydroxocobalamin—Headache—Docetaxel—prostate cancer	4.24e-05	0.000316	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Doxorubicin—prostate cancer	4.22e-05	0.000315	CcSEcCtD
Hydroxocobalamin—Oedema—Doxorubicin—prostate cancer	4.22e-05	0.000315	CcSEcCtD
Hydroxocobalamin—Infection—Doxorubicin—prostate cancer	4.19e-05	0.000313	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Doxorubicin—prostate cancer	4.14e-05	0.000309	CcSEcCtD
Hydroxocobalamin—Rash—Capecitabine—prostate cancer	4.13e-05	0.000308	CcSEcCtD
Hydroxocobalamin—Pruritus—Prednisone—prostate cancer	4.13e-05	0.000308	CcSEcCtD
Hydroxocobalamin—Dermatitis—Capecitabine—prostate cancer	4.13e-05	0.000308	CcSEcCtD
Hydroxocobalamin—Tachycardia—Doxorubicin—prostate cancer	4.12e-05	0.000307	CcSEcCtD
Hydroxocobalamin—Headache—Capecitabine—prostate cancer	4.1e-05	0.000306	CcSEcCtD
Hydroxocobalamin—Skin disorder—Doxorubicin—prostate cancer	4.1e-05	0.000306	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Epirubicin—prostate cancer	4.07e-05	0.000303	CcSEcCtD
Hydroxocobalamin—Nausea—Docetaxel—prostate cancer	4.02e-05	0.0003	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Epirubicin—prostate cancer	4.02e-05	0.000299	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Prednisone—prostate cancer	3.99e-05	0.000298	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Epirubicin—prostate cancer	3.94e-05	0.000294	CcSEcCtD
Hydroxocobalamin—Pain—Epirubicin—prostate cancer	3.9e-05	0.000291	CcSEcCtD
Hydroxocobalamin—Nausea—Capecitabine—prostate cancer	3.89e-05	0.00029	CcSEcCtD
Hydroxocobalamin—Dizziness—Prednisone—prostate cancer	3.86e-05	0.000288	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Doxorubicin—prostate cancer	3.76e-05	0.000281	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Epirubicin—prostate cancer	3.76e-05	0.00028	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Doxorubicin—prostate cancer	3.72e-05	0.000277	CcSEcCtD
Hydroxocobalamin—Rash—Prednisone—prostate cancer	3.68e-05	0.000274	CcSEcCtD
Hydroxocobalamin—Dermatitis—Prednisone—prostate cancer	3.68e-05	0.000274	CcSEcCtD
Hydroxocobalamin—Headache—Prednisone—prostate cancer	3.66e-05	0.000272	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.65e-05	0.000272	CcSEcCtD
Hydroxocobalamin—Urticaria—Epirubicin—prostate cancer	3.63e-05	0.00027	CcSEcCtD
Hydroxocobalamin—Pain—Doxorubicin—prostate cancer	3.61e-05	0.000269	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Epirubicin—prostate cancer	3.61e-05	0.000269	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Doxorubicin—prostate cancer	3.48e-05	0.000259	CcSEcCtD
Hydroxocobalamin—Nausea—Prednisone—prostate cancer	3.47e-05	0.000258	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Epirubicin—prostate cancer	3.36e-05	0.000251	CcSEcCtD
Hydroxocobalamin—Urticaria—Doxorubicin—prostate cancer	3.35e-05	0.00025	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Doxorubicin—prostate cancer	3.34e-05	0.000249	CcSEcCtD
Hydroxocobalamin—Pruritus—Epirubicin—prostate cancer	3.23e-05	0.000241	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Epirubicin—prostate cancer	3.12e-05	0.000233	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Doxorubicin—prostate cancer	3.11e-05	0.000232	CcSEcCtD
Hydroxocobalamin—Dizziness—Epirubicin—prostate cancer	3.02e-05	0.000225	CcSEcCtD
Hydroxocobalamin—Pruritus—Doxorubicin—prostate cancer	2.99e-05	0.000223	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Doxorubicin—prostate cancer	2.89e-05	0.000215	CcSEcCtD
Hydroxocobalamin—Rash—Epirubicin—prostate cancer	2.88e-05	0.000214	CcSEcCtD
Hydroxocobalamin—Dermatitis—Epirubicin—prostate cancer	2.87e-05	0.000214	CcSEcCtD
Hydroxocobalamin—Headache—Epirubicin—prostate cancer	2.86e-05	0.000213	CcSEcCtD
Hydroxocobalamin—Dizziness—Doxorubicin—prostate cancer	2.79e-05	0.000208	CcSEcCtD
Hydroxocobalamin—Nausea—Epirubicin—prostate cancer	2.71e-05	0.000202	CcSEcCtD
Hydroxocobalamin—Rash—Doxorubicin—prostate cancer	2.66e-05	0.000198	CcSEcCtD
Hydroxocobalamin—Dermatitis—Doxorubicin—prostate cancer	2.66e-05	0.000198	CcSEcCtD
Hydroxocobalamin—Headache—Doxorubicin—prostate cancer	2.65e-05	0.000197	CcSEcCtD
Hydroxocobalamin—Nausea—Doxorubicin—prostate cancer	2.51e-05	0.000187	CcSEcCtD
Hydroxocobalamin—CUBN—Disease—SRC—prostate cancer	4.75e-06	2.87e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—prostate cancer	4.73e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—prostate cancer	4.73e-06	2.85e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CD—prostate cancer	4.68e-06	2.82e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTEN—prostate cancer	4.65e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—EP300—prostate cancer	4.65e-06	2.8e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—EP300—prostate cancer	4.65e-06	2.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—prostate cancer	4.65e-06	2.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TERT—prostate cancer	4.63e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CDKN1A—prostate cancer	4.62e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—MYC—prostate cancer	4.62e-06	2.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PTEN—prostate cancer	4.61e-06	2.78e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PIK3CA—prostate cancer	4.61e-06	2.78e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—prostate cancer	4.61e-06	2.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—TLR4—prostate cancer	4.59e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MAP2K1—prostate cancer	4.59e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—STAT3—prostate cancer	4.59e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EP300—prostate cancer	4.58e-06	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1B—prostate cancer	4.57e-06	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CD—prostate cancer	4.56e-06	2.75e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—PIK3CA—prostate cancer	4.54e-06	2.74e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—prostate cancer	4.52e-06	2.72e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SERPINE1—prostate cancer	4.51e-06	2.72e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—KRAS—prostate cancer	4.47e-06	2.7e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—KRAS—prostate cancer	4.47e-06	2.7e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SRC—prostate cancer	4.46e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—EP300—prostate cancer	4.44e-06	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCQ—prostate cancer	4.43e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NGFR—prostate cancer	4.43e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—prostate cancer	4.43e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—prostate cancer	4.43e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NOS3—prostate cancer	4.42e-06	2.67e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—prostate cancer	4.4e-06	2.65e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—prostate cancer	4.39e-06	2.65e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—prostate cancer	4.39e-06	2.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAP3K7—prostate cancer	4.38e-06	2.64e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BAD—prostate cancer	4.36e-06	2.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—FGF2—prostate cancer	4.36e-06	2.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CG—prostate cancer	4.34e-06	2.62e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CTNNB1—prostate cancer	4.32e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS3—prostate cancer	4.3e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTEN—prostate cancer	4.29e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CAV1—prostate cancer	4.28e-06	2.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—prostate cancer	4.28e-06	2.58e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—KRAS—prostate cancer	4.27e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—MYC—prostate cancer	4.26e-06	2.57e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—prostate cancer	4.25e-06	2.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—CDKN1A—prostate cancer	4.22e-06	2.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF10—prostate cancer	4.21e-06	2.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTEN—prostate cancer	4.21e-06	2.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—JAK2—prostate cancer	4.18e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGF—prostate cancer	4.18e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRS1—prostate cancer	4.18e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—prostate cancer	4.17e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRB2—prostate cancer	4.17e-06	2.51e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—PIK3CA—prostate cancer	4.15e-06	2.5e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—PIK3CA—prostate cancer	4.15e-06	2.5e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—INS—prostate cancer	4.11e-06	2.48e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PIK3CA—prostate cancer	4.11e-06	2.48e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PIK3CA—prostate cancer	4.11e-06	2.48e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—EP300—prostate cancer	4.09e-06	2.47e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MDM2—prostate cancer	4.08e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—prostate cancer	4.08e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CB—prostate cancer	4.08e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VAV3—prostate cancer	4.06e-06	2.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—GSK3B—prostate cancer	4.06e-06	2.45e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—prostate cancer	4.05e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—prostate cancer	4.05e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—prostate cancer	4.04e-06	2.44e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—BAD—prostate cancer	4.03e-06	2.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CREBBP—prostate cancer	4.03e-06	2.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—ERBB2—prostate cancer	4.03e-06	2.43e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EP300—prostate cancer	4.02e-06	2.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFBR2—prostate cancer	4.01e-06	2.42e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CB—prostate cancer	3.97e-06	2.4e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ITPR1—prostate cancer	3.94e-06	2.38e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—KRAS—prostate cancer	3.94e-06	2.37e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—prostate cancer	3.94e-06	2.37e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PIK3CA—prostate cancer	3.92e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CREBBP—prostate cancer	3.92e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—prostate cancer	3.91e-06	2.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—prostate cancer	3.9e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APC—prostate cancer	3.9e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDH1—prostate cancer	3.89e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PIK3CA—prostate cancer	3.86e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGF—prostate cancer	3.86e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IRS1—prostate cancer	3.86e-06	2.33e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CD—prostate cancer	3.82e-06	2.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—prostate cancer	3.77e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—STAT3—prostate cancer	3.77e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—prostate cancer	3.77e-06	2.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—prostate cancer	3.75e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—GSK3B—prostate cancer	3.75e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MAP2K1—prostate cancer	3.74e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1B—prostate cancer	3.73e-06	2.25e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CD—prostate cancer	3.72e-06	2.24e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—prostate cancer	3.71e-06	2.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—INS—prostate cancer	3.69e-06	2.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—KRAS—prostate cancer	3.69e-06	2.22e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—prostate cancer	3.64e-06	2.19e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—prostate cancer	3.64e-06	2.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CREBBP—prostate cancer	3.62e-06	2.18e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PIK3CA—prostate cancer	3.62e-06	2.18e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LPL—prostate cancer	3.61e-06	2.18e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NOS3—prostate cancer	3.6e-06	2.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PDGFRB—prostate cancer	3.58e-06	2.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—FGF2—prostate cancer	3.56e-06	2.15e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—KRAS—prostate cancer	3.54e-06	2.14e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTEN—prostate cancer	3.53e-06	2.13e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CTNNB1—prostate cancer	3.52e-06	2.12e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—MYC—prostate cancer	3.5e-06	2.11e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—prostate cancer	3.49e-06	2.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ITGB3—prostate cancer	3.49e-06	2.1e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—prostate cancer	3.47e-06	2.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MAP2K1—prostate cancer	3.45e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3CA—prostate cancer	3.44e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3CA—prostate cancer	3.44e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CDKN1A—prostate cancer	3.44e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTEN—prostate cancer	3.43e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CD—prostate cancer	3.43e-06	2.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—prostate cancer	3.42e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—JAK2—prostate cancer	3.41e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SERPINE1—prostate cancer	3.39e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—prostate cancer	3.39e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—prostate cancer	3.39e-06	2.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3CA—prostate cancer	3.39e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB3—prostate cancer	3.38e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGFR2—prostate cancer	3.38e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—prostate cancer	3.38e-06	2.04e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—EP300—prostate cancer	3.36e-06	2.03e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—prostate cancer	3.36e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—prostate cancer	3.36e-06	2.02e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—MDM2—prostate cancer	3.33e-06	2.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CB—prostate cancer	3.33e-06	2.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—prostate cancer	3.3e-06	1.99e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—FGF2—prostate cancer	3.28e-06	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3CA—prostate cancer	3.28e-06	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ERBB2—prostate cancer	3.28e-06	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EP300—prostate cancer	3.27e-06	1.97e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3CA—prostate cancer	3.26e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TERT—prostate cancer	3.24e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS3—prostate cancer	3.24e-06	1.95e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CB—prostate cancer	3.24e-06	1.95e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—KRAS—prostate cancer	3.23e-06	1.95e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—prostate cancer	3.2e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—prostate cancer	3.2e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—prostate cancer	3.18e-06	1.92e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—prostate cancer	3.15e-06	1.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—JAK2—prostate cancer	3.15e-06	1.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—prostate cancer	3.1e-06	1.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MDM2—prostate cancer	3.07e-06	1.85e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—STAT3—prostate cancer	3.07e-06	1.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1B—prostate cancer	3.04e-06	1.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ERBB2—prostate cancer	3.03e-06	1.83e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3CA—prostate cancer	3.03e-06	1.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LEP—prostate cancer	3.03e-06	1.83e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—prostate cancer	3e-06	1.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CAV1—prostate cancer	3e-06	1.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CB—prostate cancer	2.99e-06	1.8e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL2—prostate cancer	2.97e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3CA—prostate cancer	2.97e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KDR—prostate cancer	2.97e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—prostate cancer	2.96e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—prostate cancer	2.95e-06	1.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ESR1—prostate cancer	2.89e-06	1.74e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTEN—prostate cancer	2.87e-06	1.73e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CTNNB1—prostate cancer	2.87e-06	1.73e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MYC—prostate cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—prostate cancer	2.85e-06	1.72e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—BAD—prostate cancer	2.82e-06	1.7e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—prostate cancer	2.81e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—prostate cancer	2.81e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1B—prostate cancer	2.81e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CDKN1A—prostate cancer	2.81e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PTEN—prostate cancer	2.8e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—prostate cancer	2.79e-06	1.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—prostate cancer	2.77e-06	1.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—EP300—prostate cancer	2.74e-06	1.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APC—prostate cancer	2.73e-06	1.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CG—prostate cancer	2.73e-06	1.65e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGF—prostate cancer	2.7e-06	1.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IRS1—prostate cancer	2.7e-06	1.63e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—prostate cancer	2.68e-06	1.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EP300—prostate cancer	2.67e-06	1.61e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—prostate cancer	2.66e-06	1.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CTNNB1—prostate cancer	2.65e-06	1.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—KRAS—prostate cancer	2.64e-06	1.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—prostate cancer	2.63e-06	1.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GSK3B—prostate cancer	2.62e-06	1.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—prostate cancer	2.6e-06	1.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN1A—prostate cancer	2.59e-06	1.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INS—prostate cancer	2.59e-06	1.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTEN—prostate cancer	2.58e-06	1.56e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CREBBP—prostate cancer	2.53e-06	1.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—STAT3—prostate cancer	2.5e-06	1.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—prostate cancer	2.5e-06	1.51e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3CA—prostate cancer	2.49e-06	1.5e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—prostate cancer	2.47e-06	1.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EP300—prostate cancer	2.46e-06	1.49e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—prostate cancer	2.43e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3CA—prostate cancer	2.42e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MAP2K1—prostate cancer	2.42e-06	1.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CD—prostate cancer	2.4e-06	1.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—prostate cancer	2.4e-06	1.45e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SERPINE1—prostate cancer	2.38e-06	1.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—STAT3—prostate cancer	2.31e-06	1.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—FGF2—prostate cancer	2.3e-06	1.39e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—prostate cancer	2.27e-06	1.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOS3—prostate cancer	2.27e-06	1.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—JAK2—prostate cancer	2.2e-06	1.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MDM2—prostate cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—KRAS—prostate cancer	2.15e-06	1.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MYC—prostate cancer	2.15e-06	1.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—prostate cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—prostate cancer	2.14e-06	1.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ERBB2—prostate cancer	2.12e-06	1.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—prostate cancer	2.1e-06	1.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CB—prostate cancer	2.09e-06	1.26e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—prostate cancer	2.03e-06	1.23e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3CA—prostate cancer	2.03e-06	1.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL8—prostate cancer	2.01e-06	1.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—KRAS—prostate cancer	1.98e-06	1.2e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—prostate cancer	1.98e-06	1.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3CA—prostate cancer	1.97e-06	1.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1B—prostate cancer	1.97e-06	1.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—prostate cancer	1.93e-06	1.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL2—prostate cancer	1.92e-06	1.16e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCND1—prostate cancer	1.87e-06	1.13e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CTNNB1—prostate cancer	1.86e-06	1.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3CA—prostate cancer	1.82e-06	1.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—prostate cancer	1.82e-06	1.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN1A—prostate cancer	1.81e-06	1.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTEN—prostate cancer	1.81e-06	1.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—prostate cancer	1.75e-06	1.05e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EP300—prostate cancer	1.73e-06	1.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—prostate cancer	1.68e-06	1.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—prostate cancer	1.66e-06	9.99e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—prostate cancer	1.63e-06	9.86e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—STAT3—prostate cancer	1.62e-06	9.76e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—prostate cancer	1.61e-06	9.73e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—prostate cancer	1.61e-06	9.73e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MYC—prostate cancer	1.5e-06	9.07e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—prostate cancer	1.5e-06	9.05e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—prostate cancer	1.49e-06	8.98e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—prostate cancer	1.47e-06	8.87e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—KRAS—prostate cancer	1.39e-06	8.38e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3CA—prostate cancer	1.28e-06	7.7e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TP53—prostate cancer	1.23e-06	7.45e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—prostate cancer	1.13e-06	6.82e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—prostate cancer	1.04e-06	6.29e-06	CbGpPWpGaD
